Journals / Türk Nefroloji Diyaliz ve Transplantasyon Dergisi / 2014 / Cilt: 23 - Sayı: 2

The effect of zofenopril on pancreas, kidney and liver of diabetic rats

Diyabetik ratlarda karaciğer, böbrek ve pankreas hasarında zofenoprilin etkisi

Pages
118–124
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION: In conclusion, zofenopril may be effective on the renal complications of diabetes mellitus.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Oxidative stress is responsible for some important complications of diabetes mellitus.
📊
Key Findings & Data:Zofenopril, which has an antioxidant effect, may decrease the oxidative stress of the diabetic microenvironment.
💡
Conclusion & Impact:CONCLUSION: In conclusion, zofenopril may be effective on the renal complications of diabetes mellitus.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: Oxidative stress is responsible for some important complications of diabetes mellitus. Zofenopril, which has an antioxidant effect, may decrease the oxidative stress of the diabetic microenvironment. The aim of our study was to evaluate the effect of zofenopril in the liver, pancreas and kidney of alloxan-induced diabetic rats. MATERIAL and METHODS: Rats were divided into five groups: control group (n=6), rats treated with zonenopril (50 mg/kg/day, orally four weeks; n=6), rats exposed to alloxane (120 mg/kg single dose intraperitoneal injection, n=6), rats administered alloxan+zofenopril (n=6) and rats administered insulin plus alloxan.RESULTS: After one month, we observed histological improvement in the kidneys but not in thepancreas and liver. CONCLUSION: In conclusion, zofenopril may be effective on the renal complications of diabetes mellitus.

Özet

AMAÇ: Oksidatif stres, sistemik bir hastalık olan diyabetin komplikasyonların önemli bir kısmından sorumludur. Antioksidan bir ajan olan zofenoprilin oksidatif hasara bağlı komplikasyonları azalttığı bilinmektedir. Çalışmamızın amacı alloksanla diyabeti indüklenen ratlarda karaciğer, böbrek vepankreas hasarı üzerine zofenoprilin etkilerini ışık mikroskopu altında değerlendirmekti.GEREÇ ve YÖNTEMLER: Ratlar: kontrol grubu (n=6), zofenopril verilen grup (50 mg/kg/günoral; n=6), alloksan verilen grup (120 mg/kg tek intraperitoneal enjeksiyon; n=6), alloksan+zofenopril verilen grup (50 mg/kg gun oral zofenopril; n=6) ve insülin+alloksan verilen grup olarak 5 gruba ayrıldı. Ratlara %0,9luk NaCl solüsyonunda cözülmüş alloksanın taze hazırlanarak verilmesi yoluyla diyabet indüklendi. Zofenopril 4 hafta boyunca 50 mg/kg/gün dozda oral yolla verildi. BULGULAR: Tedavi sonrası ışık mikroskopu ile yapılan değerlendirmede zofenoprilin böbrektediyabet kaynaklı histopatolojik değişikliklerde düzelme sağladığı; ancak pankreas ve karaciğerdeönemli bir histolojik değişme oluşturmadığını gözlendi. SONUÇ: Sonuç olarak, KBHlı hastanın uygun bakım ve sevk yönetimi hayat kurtarıcıdır. KBHfarkındalığı ve yönetim kalitesini arttırmak için yeni stratejiler geliştirilmelidir.

🔖

Cite This Article

UTSAL, S., HALTAS, H., ÇARLIOĞLU, A., TURGUT, F., ALKAN, R., AKDENİZ, D., UZ, E. (2022). The effect of zofenopril on pancreas, kidney and liver of diabetic rats. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, Cilt: 23 - Sayı: 2, 118–124. https://ajindex.com/articles/636292

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Nasri H, Baradaran A, Ardalan MR, Mardani S, Momeni A, Rafieian-Kopaei M: Bright renoprotective properties of metformin: Beyond blood glucose regulatory effects. Iran J Kidney Dis 2013; 7(6): 423-428
  2. Ali DK, Oriowo M, Tovmasyan A, Batinic-Haberle I, Benov L: Late administration of Mn porphyrin-based SOD mimic enhances diabetic complications. Redox Biol 2013; 1(1): 457-466
  3. Konior A, Schramm A, Czesnikiewicz-Guzik M, Guzik TJ: NADPH Oxidases in Vascular Pathology. Antioxid Redox Signal 2013 Nov 1. (Epub ahead of print) Gradinaru D, Borsa C, Ionescu C, Margina D: Advanced oxidative and glycoxidative protein damage markers in the elderly with type 2 diabetes. J Proteomics 2013; 92: 313-322
  4. Mishra N, Singh N: Blood viscosity, lipid profile, and lipid peroxidation in type-1 diabetic patients with good and poor glycemic control. N Am J Med Sci 2013; 5(9): 562-566
  5. Mihailidou C, Papavassiliou AG, Kiaris H: A crosstalk between p21 and UPR-induced transcription factor C/EBP homologous protein (CHOP) linked to type 2 diabetes. Biochimie 2014; 99: 19-27
  6. Battacharya SK, Satyan KS, Ghosal S: Antioxidant activity of glycowithanolides from Withania somnifera. Indian J Exp Bio 1997; 35(3): 236-239
  7. Ilavarasan R, Mohideen S, Vijayalakshmi M, Manonmani G Hepatoprotective effect of Cassia angustifolia Vahl. Indian J Pharm Sci 2001; 63: 504-507
  8. Manonmani G, Anbarasi K, Balakrishna K, Veluchamy G, Shyamala Devi CS: Effect of Terminalia arjuna on the antioxidant defense system in alloxan induced diabetes in rats. Biomedicine 2002; 22 52-61
  9. Pasini AF, Garbin U, Nava MC, Stranieri C, Pellegrini M Boccioletti V, Luchetta ML, Fabrizzi P, Lo Cascio V, Cominacin L: Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients. Am J Hypertens 2007; 20(4): 443-450
  10. Balazs M, Halmos T: Electron microscopic study of liver fibrosis associated with diabetes mellitus. Exp Pathol 1985; 27: 153-162
  11. Tolman, KG, Fonseca V, Tan MH, Dalpiaz A: Narrative reviewHepatobiliary disease in type 2 diyabetes mellitus. Ann Intern Med 2004; 141: 946-956
  12. Kume E, Fujimura H, Matsuki N, Ito M, Aruga C, Torium W, Kitamura K, Doi K: Hepatic changes in the acute phase of streptozotocin (SZ)-induced diabetes in mice. Exp Toxicol Patho 2004; 55(6): 467-480
  13. Lenk SE, Bhat D, Blakeney W, Dunn WA Jr: Effects of streptozotocin-induced diabetes on rough endoplasmic reticulum and lysosomes of rat liver. Am J Physiol 1992; 263: E856–E862 Baynes JW,